Shares of UnitedHealth Group Incorporated (NYSE:UNH – Get Free Report) traded down 5.1% during trading on Monday after Morgan Stanley lowered their price target on the stock from $664.00 to $563.00. Morgan Stanley currently has an overweight rating on the stock. UnitedHealth Group traded as low as $431.98 and last traded at $431.11. 3,667,024 shares changed hands during trading, a decline of 32% from the average session volume of 5,425,924 shares. The stock had previously closed at $454.11.
A number of other brokerages have also recently issued reports on UNH. Oppenheimer reduced their price objective on UnitedHealth Group from $640.00 to $600.00 and set an “outperform” rating on the stock in a research note on Monday. Barclays decreased their price target on UnitedHealth Group from $642.00 to $560.00 and set an “overweight” rating on the stock in a research note on Monday. Argus cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Monday. Truist Financial dropped their price target on shares of UnitedHealth Group from $660.00 to $580.00 and set a “buy” rating for the company in a research report on Monday. Finally, HSBC reaffirmed a “hold” rating and set a $490.00 price objective on shares of UnitedHealth Group in a research note on Tuesday. Two equities research analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and four have given a strong buy rating to the stock. According to MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Buy” and an average target price of $608.00.
View Our Latest Stock Analysis on UnitedHealth Group
Institutional Investors Weigh In On UnitedHealth Group
UnitedHealth Group Trading Up 0.4 %
The firm has a market capitalization of $390.67 billion, a PE ratio of 27.55, a P/E/G ratio of 1.37 and a beta of 0.61. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The firm has a 50 day simple moving average of $508.83 and a 200 day simple moving average of $537.99.
UnitedHealth Group (NYSE:UNH – Get Free Report) last announced its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $109.58 billion during the quarter, compared to the consensus estimate of $111.56 billion. During the same quarter in the prior year, the firm earned $6.91 earnings per share. Equities analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.
UnitedHealth Group Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were paid a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.97%. UnitedHealth Group’s dividend payout ratio is currently 35.18%.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Further Reading
- Five stocks we like better than UnitedHealth Group
- What is the Dogs of the Dow Strategy? Overview and Examples
- How to Invest in Micro-Cap Stocks Like a Pro
- 3 Fintech Stocks With Good 2021 Prospects
- Investors Sell Microsoft Stock on OpenAI News—Time to Buy?
- What is the S&P 500 and How It is Distinct from Other Indexes
- Take-Two Interactive: A Defensive Play Set to Explode
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.